- Corporate Officers - M
- Monaghan Matthew E.
Insider Trading History of Monaghan Matthew E.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Monaghan Matthew E. since 2016.
This trader's CIK number is 1638490.
At the time of last reporting, Monaghan Matthew E. was the Director of Syneos Health, Inc.. (stock ticker symbol SYNH).
Also see all insider trading activities at Syneos Health, Inc..
Note that in the past
Monaghan Matthew E. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Invacare Corp (IVC) by Monaghan Matthew E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | IVC | 33,000 | $49,104 | 0 | $0 | 0 | $0 |
| 2018 | IVC | 13,750 | $99,852 | 0 | $0 | 0 | $0 |
| 2016 | IVC | 15,500 | $150,255 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Syneos Health, Inc. (SYNH) by Monaghan Matthew E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | SYNH | 0 | $0 | 200 | $14,869 | 0 | $0 |
| 2021 | SYNH | 0 | $0 | 170 | $15,068 | 0 | $0 |
Insider trading activities at 2 companies by Monaghan Matthew E.:
1. Invacare Corp (IVC)
2. Syneos Health, Inc. (SYNH)
Table 1. Insider trading of Invacare Corp (IVC) by Monaghan Matthew E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-03-11 | IVC | Buy | 33,000 | 1.49 | 49,104 |
| 2018-11-08 | IVC | Buy | 13,750 | 7.26 | 99,852 |
| 2016-11-02 | IVC | Buy | 11,000 | 9.00 | 99,000 |
| 2016-05-03 | IVC | Buy | 4,500 | 11.39 | 51,255 |
Table 2. Insider trading of Syneos Health, Inc. (SYNH) by Monaghan Matthew E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-31 | SYNH | Sale | 200 | 74.35 | 14,869 |
| 2021-07-16 | SYNH | Sale | 170 | 88.64 | 15,068 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Monaghan Matthew E.
(Director of Syneos Health, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.